1. Home
  2. ICCC vs RACC Comparison

ICCC vs RACC Comparison

Compare ICCC & RACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.41

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

RACC

Research Alliance Corporation III Class A Ordinary Shares

N/A

Current Price

$11.20

Market Cap

102.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ICCC
RACC
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
102.8M
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
ICCC
RACC
Price
$10.41
$11.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.4K
3.2K
Earning Date
05-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.21
N/A
Revenue
$26,493,169.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.90
N/A
Revenue Growth
51.64
N/A
52 Week Low
$4.52
$10.39
52 Week High
$11.16
$12.38

Technical Indicators

Market Signals
Indicator
ICCC
RACC
Relative Strength Index (RSI) 57.62 100.00
Support Level $9.27 $10.40
Resistance Level $10.75 $12.38
Average True Range (ATR) 0.47 0.69
MACD 0.02 0.10
Stochastic Oscillator 55.24 48.24

Price Performance

Historical Comparison
ICCC
RACC

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About RACC Research Alliance Corporation III Class A Ordinary Shares

Research Alliance Corporation III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: